Schedule 13G ownership disclosure

MEDICENNA THERAPEUTICS CORP

Security class unavailable · CUSIP: 58490H107

Event date: 2024-10-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,510,944
Percent of class
8.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000012208-24-000058
Form type
SC 13G/A
Filer
BIO-RAD LABORATORIES, INC.
CIK
CIK 12208
Filed
Oct 24, 2024
Reporting period
Oct 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub